Stockscreener 앱 받기
2.50
3.85%
-0.10
시간 외 거래:
2.42
-0.08
-3.20%
Ezfill Holdings Inc 주식(EZFL)의 최신 뉴스
EzFill stock hits 52-week low at $2.19 amid market challenges By Investing.com - Investing.com South Africa
EZFill Holdings Inc. announced that it has received $0.2 million in funding - Marketscreener.com
EzFill stock hits 52-week low at $2.19 amid market challenges - Investing.com
EZFill Holdings Inc. announced that it expects to receive $0.165 million in funding from NextNRG Holding Corp. - Marketscreener.com
EzFill secures $181.5K loan with NextNRG Holding - Investing.com
EzFill secures $181.5K loan with NextNRG Holding By Investing.com - Investing.com UK
EzFill Holdings Reports Strong Q3 2024 Growth - TipRanks
EZFLEzFill Holdings, Inc. Latest Stock News & Market Updates - StockTitan
EzFill Announces 2024 Third Quarter Financial Results - GlobeNewswire
EzFill Q3 Revenue Climbs 13%, Delivers Record 1.87M Gallons Amid Strong Growth | EZFL Stock News - StockTitan
Yoshi Mobility Agrees to Sell Its Fleet Fueling Operation to EZFill Holdings - NGT News
Frist's Yoshi Mobility sells fuel division - The Business Journals
EzFill to acquire Yoshi fueling division, eyes national expansion - Investing.com
EzFill Fueling up to Expand Nationally Enters into LOI for the Acquisition of Yoshi Mobility’s Fuel Division - GlobeNewswire
Yoshi Mobility goes green, spins off fueling division - StockTitan
EZFill Holdings Inc. signed a letter of intent to acquire Fueling division of Yoshi, Inc. - Marketscreener.com
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and Milton - GlobeNewswire
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and - EIN News
EzFill Holdings revises share exchange in NextNRG acquisition - Investing.com
EzFill Holdings revises share exchange in NextNRG acquisition By Investing.com - Investing.com Canada
EZFill Holdings Inc. (NASDAQ:EZFL) Short Interest Down 56.5% in September - Defense World
FDA Approves Miplyffa for Niemann-Pick Disease, Type C - MyChesCo
FDA Approves Miplyffa for Ultra Rare Niemann-Pick Disease Type C - Managed Healthcare Executive
FDA approves Zevra’s Miplyffa for Niemann-Pick disease type C treatment - World Pharmaceutical Frontiers
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 - Investing.com
Ezzaty Abdullah admits to be delivering her baby soon - Yahoo Lifestyle Singapore
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease - Pharmaceutical Technology
FDA clears first drug for Niemann-Pick disease - pharmaphorum
Zevra’s Miplyffa wins first FDA approval in Niemann-Pick type C - BioWorld Online
EzFill Holdings (NASDAQ:EZFL) Stock Quotes, Forecast and News Summary - Benzinga
After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa - FiercePharma
First Drug Approved for Niemann-Pick Disease Type C - Medpage Today
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease - Benzinga
Arimoclomol Becomes First FDA Approved Treatment for Neimann-Pick Disease Type C - Pharmacy Times
FDA approves first Niemann-Pick disease, type C treatment - The Pharma Letter
FDA approves arimoclomol as first drug to treat Neimann-Pick disease, type C - Contemporary Pediatrics
EZFill Holdings Inc. (NASDAQ:EZFL) CTO Sells $20,550.00 in Stock - Defense World
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k - Investing.com India
Extra Storage rises on Jefferies upgrade - XM
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 - Investing.com India
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 By Investing.com - Investing.com Australia
Correction to Eli Lilly Gets FDA Approval for Eczema Treatment Article - Morningstar
Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss - MarketWatch
FDA Approves Eli Lilly's Drug for Eczema - Newsmax
Insider Sale: CTO Avishai Vaknin Sells Shares of EzFill Holdings Inc (EZFL) By GuruFocus - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock By Investing.com - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock - Investing.com
EzFill holdings CTO Avishai Vaknin sells shares worth over $15k - Investing.com
EzFill regains compliance with Nasdaq's equity rule - Investing.com
EzFill Holdings Regains Nasdaq Compliance, Faces Monitoring - TipRanks
EzFill Holdings, Inc. Regains Compliance with NASDAQ Listing Standard - GlobeNewswire
16.16%
2.00%
자본화:
|
볼륨(24시간):